Founded: 2020
pi Investment: September 2021
Founders: Aridni Shah, Trisha Chatterjee
Website: https://www.immunitoai.com/
immunitoAI is a biotech startup that aims to make targeted therapy using antibodies a norm. It is developing an AI-powered platform for antibody discovery and screening. The platform screens and ranks the best antibody candidates for a given target/antigen. With this technology, the discovery process can be made 2x more efficient while improving the success rate.
15
Companies Funded
$30M (INR 225Cr)
Fund Corpus
Seed, Pre-Series A, Series A
Stage Focus
$500K - $2M
Ticket Size
Our core team brings decades of operating experience in building disruptive technology companies, business strategy, and global investments. While we bring diverse perspectives, we are bound by a shared passion for backing bold entrepreneurs in DeepTech. We believe in conviction-led investing and supporting our founders throughout their journey.
Strong participation from existing and new LPs
Fund II will look at companies focused on disruptive AI and other forms of Deep Tech across sectors including but not limited to Blockchain, Spacetech, Biotech, Material Science, etc. Through a corpus that is 3x as large as Fund I, we will aim to go deeper in portfolio winners in subsequent rounds.
AI for Marketing Automation
Pixis is a no code AI platform for fully automated creative generation and targeted marketing campaigns to achieve significant marketing RoI for its customers currently across India, NA, and EU.
AI for Antibody Discovery & Screening
immunitoAI is developing an AI-powered platform for antibody discovery and screening. The platform screens and ranks the best antibody candidates for a given target/antigen. With this technology, the discovery process can be made 2x more efficient while improving the success rate.
Ai Palette predicts trends for F&B companies
Ai Palette's Foresight Engine uses sophisticated NLP models and image recognition trained on F&B datasets to deliver significant product innovation time and cost savings for clients.
© 2021